LCTX
Price
$1.20
Change
-$0.01 (-0.83%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
301.65M
64 days until earnings call
Intraday BUY SELL Signals
NKTX
Price
$2.70
Change
-$0.21 (-7.22%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
208.2M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LCTX vs NKTX

Header iconLCTX vs NKTX Comparison
Open Charts LCTX vs NKTXBanner chart's image
LCTX vs NKTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LCTX vs. NKTX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Hold and NKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (LCTX: $1.21 vs. NKTX: $2.91)
Brand notoriety: LCTX and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 140% vs. NKTX: 57%
Market capitalization -- LCTX: $301.65M vs. NKTX: $208.2M
LCTX [@Biotechnology] is valued at $301.65M. NKTX’s [@Biotechnology] market capitalization is $208.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than LCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 3 TA indicator(s) are bullish while NKTX’s TA Score has 3 bullish TA indicator(s).

  • LCTX’s TA Score: 3 bullish, 5 bearish.
  • NKTX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than LCTX.

Price Growth

LCTX (@Biotechnology) experienced а -6.20% price change this week, while NKTX (@Biotechnology) price change was -4.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

LCTX is expected to report earnings on Aug 06, 2026.

NKTX is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LCTX($302M) has a higher market cap than NKTX($208M). NKTX YTD gains are higher at: 57.297 vs. LCTX (-27.545). LCTX has higher annual earnings (EBITDA): -22.14M vs. NKTX (-112.74M). NKTX has more cash in the bank: 282M vs. LCTX (53.4M). LCTX has less debt than NKTX: LCTX (2.39M) vs NKTX (76.6M). LCTX has higher revenues than NKTX: LCTX (14.8M) vs NKTX (0).
LCTXNKTXLCTX / NKTX
Capitalization302M208M145%
EBITDA-22.14M-112.74M20%
Gain YTD-27.54557.297-48%
P/E RatioN/AN/A-
Revenue14.8M0-
Total Cash53.4M282M19%
Total Debt2.39M76.6M3%
FUNDAMENTALS RATINGS
LCTX vs NKTX: Fundamental Ratings
LCTX
NKTX
OUTLOOK RATING
1..100
637
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
6239
P/E GROWTH RATING
1..100
59100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NKTX's Valuation (9) in the null industry is somewhat better than the same rating for LCTX (55). This means that NKTX’s stock grew somewhat faster than LCTX’s over the last 12 months.

NKTX's Profit vs Risk Rating (100) in the null industry is in the same range as LCTX (100). This means that NKTX’s stock grew similarly to LCTX’s over the last 12 months.

NKTX's SMR Rating (98) in the null industry is in the same range as LCTX (99). This means that NKTX’s stock grew similarly to LCTX’s over the last 12 months.

NKTX's Price Growth Rating (39) in the null industry is in the same range as LCTX (62). This means that NKTX’s stock grew similarly to LCTX’s over the last 12 months.

LCTX's P/E Growth Rating (59) in the null industry is somewhat better than the same rating for NKTX (100). This means that LCTX’s stock grew somewhat faster than NKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXNKTX
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
LCTX
Daily Signal:
Gain/Loss:
NKTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DCSYX72.310.30
+0.42%
Davis Balanced Fund Y
MMELX13.84N/A
N/A
MassMutual Mid Cap Growth Adm
ACETX11.53N/A
N/A
Invesco Equity and Income Y
BIBDX13.02N/A
N/A
BlackRock Global Dividend Instl
ALMZX31.52N/A
N/A
Alger MidCap Growth Institutional Z-2

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
-3.97%
MDGL - LCTX
43%
Loosely correlated
-5.90%
NKTX - LCTX
39%
Loosely correlated
-7.32%
IDYA - LCTX
38%
Loosely correlated
-3.70%
CRBU - LCTX
38%
Loosely correlated
-4.32%
MGX - LCTX
37%
Loosely correlated
+1.53%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with RXRX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-7.32%
RXRX - NKTX
50%
Loosely correlated
-4.62%
EDIT - NKTX
49%
Loosely correlated
-15.72%
FATE - NKTX
49%
Loosely correlated
-6.39%
RCKT - NKTX
48%
Loosely correlated
-4.30%
BEAM - NKTX
48%
Loosely correlated
-7.00%
More